Original Research

Headache and Facial Pain

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial

Lipton RB, Thiry A, Morris BA, Croop R

Journal of Pain Research 2024, 17:2431-2441

Published Date: 22 July 2024